Kevin Koh

- Lead negotiations with tech transfer offices of leading clinical research institutes, leading to exclusive technology licensing agreements signed - Developed KLARO®, an in vivo surgical lighting device, now commercially distributed with US FDA & CE Mark approvals attained - Launched the ENLYT® portable endoscope system for cancer screening and imaging of nasopharyngeal conditions in both clinical and primary care settings - Pioneered the ERES™ endoscopic surgical robot, a novel robotic add-on to any standard endoscope, conferring robotic capabilities to the user - Signed a landmark MOU with Singapore General Hospital as the company's first Centre of Excellence Prizes, Awards & Recognitions: • SLINGSHOT 2024 - Top 10 Global Healthcare Startups (Oct 2024) • WIPO Global Awards 2024 Winner (Jul 2024) • Johnson & Johnson Innovation - JLABS Singapore Residency (from May 2024) • MedTech Innovator APAC 2023 - Top 4 Grand Finalist (Dec 2023) • MedTech Innovator APAC 2023 - Cambridge Consultants Product Development Prize (Dec 2023) • WIPO-IPOS IP for Innovation Awards 2022 - Winners Trophy (Sep 2022) • Mount Sinai Innovation Partners - Elementa Labs Incubatee (Apr 2022) • Nex Cubed - Innovation Launchpad Program Participant (July 2021) Research & Commercialisation Grants: • Enterprise Singapore - EDG (Innovation & Productivity) (Jun 2025) • Suzhou Industrial Park Tech Pioneer Award (Jan 2024) • A*STAR-Suzhou Industrial Park Technology Support Grant (Sep 2023) • Enterprise Singapore - EDG (Innovation & Productivity) (Nov 2022) • Enterprise Singapore - EDG (Core Capabilities) (Aug 2021) • A*STAR-SingHealth Medical Catalyst Programme (MedCaP) Grant (Sep 2019) • National Institutes of Health (USA) R01 Grant (Jul 2019) • National Health Innovation Centre (NHIC) - Innovation to Protect (I2P) Grant (Apr 2018) • Duke/Duke-NUS Collaboration Pilot Project Award (Feb 2016) • National Healthcare Innovation Centre (NHIC) Innovation to Develop (I2D) Grant (Oct 2015)

- For Singapore & Malaysia - Chairman of the Board - FY 2024

- VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer.

- Industry Mentor to the Duke-NUS Health Innovator Programme at the Office of Innovation and Entrepreneurship, Duke-NUS Medical School (National University of Singapore) - Mentee Team FemTech (Cohort 1 - 2023) won 1st Place at the inaugural shark tank challenge of the DHIP programme, comprising judges from industry, government and academia - Mentee Team ColoCorrect (Cohort 4 - 2025) currently in progress.

- Founding Director of Metropolitan Event Productions Pte Ltd and Metropolitan Concert Services Pte Ltd, co-managers of the Metropolitan Festival Orchestra (MFO). - First to pioneer the live movie-concert performance concept in Asia with the groundbreaking Asian premieres of The Lord of The Rings - The Fellowship of The Ring (2013) & The Two Towers (2014) movie-concert productions. - Special partner of INSEAD Business School for "Leadership through Performance - A Symphony in Collaboration" as part of the INSEAD MBA and Advanced Management Programme.

- PathoVax is a new biotechnology start-up focused on the development of a universal Human Papillomavirus (HPV) vaccine to provide prophylaxis against all HPV-related cancers and diseases - Our pilot vaccine, RGVax, promises to provide protection against all 15 oncogenic HPVs and many others that cause various warts - Grants awarded: • NCI Grant for GMP manufacturing, toxicology & IND 2014 • Maryland Innovation Initiative Grant 2015 - Awards & Prizes: • OneStart Americas' Top 10 Healthcare Startups of 2016 • 43North Business Plan Competition - Finalist 2016 • MassChallenge Boston - Finalist 2016 • Harvard Innovation Lab - Venture Incubation Program 2016

- Commercial research & development ongoing for a novel point-of-care saliva-based diagnostic kit for an endemic Asian tropical disease. - Awarded the ISO 113485:2016 Certification - Research Commercialisation Grants awarded: • SPRING-Agency for Science Technology & Research (A*STAR) - T-Up Grant 2015 • SPRING Technology Enterprise Commercialisation Scheme (TECS) - Proof-of-Value (POV) Grant 2015 - Awards & Prizes: • Finalist - TechVenture Start-Up Challenge 2015 • 1st Runner Up Prize - Tech Plan Grand Prix 2015 • Japan Tobacco Venture Prize - Tech Planter BioScience Grand Prix 2015

- Mergers & Acquisitions and Structured Finance advisory - Debt restructuring - Capital raising for venture capital and private equity investments - Experienced in both buy- and sell-side mandates over a range of industries, including: Technology, F&B, Education, Consumer Entertainment, Manufacturing, Medical Devices and Clinical Diagnostics.

- Launched successful marketing sales of a magnetic interference cloud (MI Cloud) based consumer health product in November 2012 - Responsible for exploring novel applications for the company's proprietary nanotechnology products in partnership with various international institutes of scientific research and higher learning - Company's breakthrough SleepEzy medical sleep-aid device conferred the prestigious "Most Innovative Product 2013" award by Guardian Pharmacy, Singapore's premiere pharmacy chain (151 stores) - SleepEzy was also conferred the "People's Choice Award 2013" (Top 21 Singaporean Brands) by My Paper (我报), one of Singapore's mainstream newspaper publications

- Chaired Asian investor meetings and managed capital raising in Asia as lead investor representative - Conducted ministerial-level discussions for 3 private hospital ventures in Vietnam with the country’s political elite

- Evaluated new medical science investment targets/initiatives conceived with and by Group Chairman Professor Sir Christopher Evans, OBE - Evaluated the Asian medical sciences commercial space for potential investment targets through meetings with stakeholders from academia, government and fund management sectors - Involved in buy-side meetings and discussions with brokers and senior management of target investment companies - Personal investor network in Asia include ultra-HNWIs, private banks and family offices

- Thesis Title: "Multimodal Multispectral Optical Endoscopic Imaging for Biomedical Applications". - Developed sound analytical, problem-solving and team-working skills as part of a multidisciplinary research group at the Institute of Global Health Innovation. - Presented at various international conferences and published in corresponding proceedings. - Winner of multiple Best Poster and Best Research Presentation prizes. - Declined 2 fully funded PhD scholarships from Cambridge University and University College London.

- Final Year Research Project: “Role of IP3 Receptors During Early Zebrafish Development” - Research Project results published in prestigious peer-reviewed scientific journal - Journal of Biological Chemistry